Co-Authors
This is a "connection" page, showing publications co-authored by Bernard La Scola and Jean-Christophe Lagier.
Connection Strength
1.780
-
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
Score: 0.222
-
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
Score: 0.218
-
Naming microorganisms: the contribution of the IHU Méditerranée Infection, Marseille, France. New Microbes New Infect. 2018 Nov; 26:S89-S95.
Score: 0.195
-
Many More Microbes in Humans: Enlarging the Microbiome Repertoire. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S20-S29.
Score: 0.182
-
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732.
Score: 0.059
-
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage. Clin Microbiol Infect. 2021 Sep; 27(9):1352.e1-1352.e5.
Score: 0.059
-
SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5).
Score: 0.059
-
COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
Score: 0.058
-
Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients? J Microbiol Immunol Infect. 2021 Oct; 54(5):997-1000.
Score: 0.058
-
Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106238.
Score: 0.058
-
Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
Score: 0.058
-
Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881.
Score: 0.057
-
Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
Score: 0.057
-
Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
Score: 0.056
-
Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France. Int J Infect Dis. 2020 Jul; 96:154-156.
Score: 0.055
-
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
Score: 0.055
-
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
Score: 0.055
-
Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020 Aug; 39(8):1601-1603.
Score: 0.055
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
Score: 0.055
-
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
Score: 0.055
-
Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8).
Score: 0.054